SEC no to clinical trial waiver for Pfizer's Covid pill

The SEC asked the companies to conduct bioavailability and bioequivalence (BA/BE) studies and submit safety data at its meeting on Friday, said people with knowledge of the matter.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3Ar5KK4
via IFTTT